School of Medicine
Showing 1-100 of 4,396 Results
-
Mohammad Abbasi, PhD
RSE / Data Scientist and Data Manager at Transitional AI lab, Psych/Public Mental Health & Population Sciences
BioI am a Research Software Engineer (RSE) | Data Scientist & Data Manager at the Stanford Translational AI (STAI) Lab. I lead data engineering and AI infrastructure across large-scale neuroscience and healthcare projects, building standards-first, end-to-end pipelines for data collection, curation, preprocessing, and multimodal integration. My work emphasizes reproducibility, scalability, and interoperability through BIDS-style schemas, schema validation, containerized deployments, and CI/CD across heterogeneous computing environments.
I have designed and maintained containerized preprocessing workflows for thousands of subjects across major datasets, automating modality-specific steps such as registration, intensity normalization, bias-field correction, motion/confound estimation, quality control, and downstream metadata exports. I ensure these pipelines are robust, well-documented, versioned, and reusable across projects, sites, and modalities. -
Oscar J. Abilez
Senior Scientist, Cardiothoracic Surgery - Pediatric Cardiac Surgery
Current Research and Scholarly InterestsDr. Abilez' interests are aimed at elucidating how various biophysical and biochemical perturbations regulate early cardiovascular development across time and length scales that span several orders of magnitude, using human pluripotent stem cells as a model system.
-
Aysha Abraibesh
Clinical Rsch Coord Assoc, Psychiatry and Behavioral Sciences - Sleep Medicine
BioAysha Abraibesh, MPA is a clinical research coordinator in the Department of Psychiatry & Behavioral Sciences at the Stanford University School of Medicine. She works primarily on the Stanford Apnea and Insomnia Study (AIR) Study, led by Dr. Rachel Manber (more info can be found at airstudy.stanford.edu)
Aysha earned her Bachelor’s degree in Psychology (2012) and Master’s in Public Administration (2013) both from Clark University in Worcester, Massachusetts. She has since held multiple positions supporting research studies related to social and behavioral health issues, most recently as a Lead Behavioral Health Interviewer at Kaiser Permanente’s Center for Health Research in Portland, Oregon. -
Emma Adair
Clinical Research Manager, Anesthesia - Adult Pain Medicine
Current Role at StanfordEmma manages the Neurology & Neurosurgery Clinical Trials Team consisting of 17 Clinical Research Coordinators conducting 70+ clinical trials in areas including: Device Neurosurgery, Functional Neurosurgery, Headache, Epilepsy, Neuroimmunology, Alzheimers/Memory Disorders, Parkinson's, Radiology, and Bio Banks.
-
Maheen Mausoof Adamson
Clinical Professor (Affiliated), Neurosurgery
Staff, Neurosurgery OperationsBioDr. Maheen Mausoof Adamson is a Clinical Professor of Neurosurgery (Affiliated) at Stanford School of Medicine, Director of Research for Women's Operational Military Exposure Network Center of Excellence (WOMENCOE), and Senior Scientist for Rehabilitation Services at VA Palo Alto Healthcare System. Adamson completed her undergraduate degrees in neurobiology and women's studies at the University of California, Irvine. She completed her Ph.D. in neuroscience from the University of Southern California and a postdoctoral fellowship in Psychiatry and Behavioral Sciences at Stanford School of Medicine. She also has a Masters in Healthcare Leadership from the School of Public Health from Brown University and is a faculty fellow for Stanford Byers Biodesign Program.
Dr. Adamson’s expertise and interests span employing translational neuroscience methodologies for diagnostic and neuromodulation treatments (such as repetitive Transcranial Magnetic Stimulation (rTMS)) for frequent health problems in patients with Traumatic Brain Injury (TBI), psychiatric problems, and Alzheimer's disease. She has employed advanced structural and functional imaging modalities and biomarker assessments for treatment response and diagnosis in Veteran, active military, and civilian populations with these health problems. She has been a leader in identifying sex differences in brain injury, particularly in the Veteran population. She currently serves as PI and Site-PI on numerous neuromodulation clinical trials and collaborates internationally to develop advanced diagnostic methods in neuroimaging, especially in underserved communities. As Director of the Adamson Lab, she is actively involved in translating research, such as neuromodulation and virtual and augmented reality, into clinical settings.
In her new role as Research Director of WOMENCOE, she is developing the research and education center to investigate and disseminate findings on the impact of military environmental exposure on reproductive health, cancer, psychiatric illness, cognitive decline, and other women's health issues. This network is funded by the VA Health Outcomes Military Exposure Center under Department of Veterans Affairs
Dr. Adamson is also the lead PI of ENIGMA-PAK study that aims to Leverage Consanguinity in Pakistan to Uncover the Genomic Architecture of Alzheimer's Disease. She has received recognition in national and international settings and serves on several editorial and industry advisory boards. She is also CEO and founder of her digital health startup Soof Solutions Inc which uses eye tracking for communication in individuals lacking the power of speech. She is also intricately involved in mentoring postdoctoral fellows, residents, undergraduates and high school students in STEM careers. -
Sophia Adelson
Rsch Data Analyst 2, Pediatrics - Genetics
BioSophia Adelson is a Research Genetic Counselor in the Department of Pediatrics, Division of Genetics at Stanford University. Her work focuses on advancing reproductive genetics and improving maternal and childhood health outcomes through clinical research and thoughtful implementation of genomic technologies. Sophia’s interest in reproductive health began during her undergraduate studies at Wellesley College, a historically women’s college that shaped her strong commitment to maternal health and reproductive justice. This foundation continues to guide her work, which centers on advancing equitable, evidence-based care for pregnant individuals, newborns, and children.
At Stanford, Sophia works closely with Dr. Christina Tise on several research initiatives at the intersection of reproductive and pediatric genetics. She contributes to the BabySeq Project, a study using genome sequencing to identify actionable genetic risks in newborns, where she coordinates IRB submissions, pediatrician engagement, family recruitment and consent, and the return of results. Sophia also plays an active role in the TRIOS Study, which investigates the genetic causes of recurrent pregnancy loss. Her work explores participants’ experiences receiving genomic results and aims to improve counseling practices and outcomes for families navigating reproductive challenges. In addition, Sophia contributes to the GREGoR Consortium (Genomics Research to Elucidate the Genetics of Rare diseases), supporting efforts to identify novel disease genes and improve diagnostic yield for individuals with rare, undiagnosed conditions.
Sophia’s research and clinical interests include reproductive and prenatal genetics, rare disease genomics, bioethics, and equitable implementation of genomic medicine. She is passionate about proactive healthcare and advocating for effective health risk communication within families, with the goal of improving understanding, decision-making, and health outcomes across diverse populations.
Research interests: reproductive genetics, prenatal genetics, recurrent pregnancy loss, newborn genomic screening, rare disease genomics, bioethics, proactive healthcare, family health communication, equitable implementation of genomics -
Ruth Adewuya
Managing Director, Center for Continuing Medical Education, School of Medicine - Post Grad Med Education (CME)
Current Role at StanfordManaging Director, Center for Continuing Medical Education (February 2018 - present)
Executive Director, Stanford Advanced Practice Provider Leadership Certificate Program (September 2022 – present)
Executive Director, Stanford Physician Leadership Certificate Program (October 2021 – present)
Podcast Host | Stanford Medcast (September 2020 – present) -
Maryam Ahmadi Shapourabadi
Social Science Research Scholar, Psychiatry and Behavioral Sciences - Sleep Medicine
Current Role at StanfordResearch Scolar
-
So Hee "Naomi" Ahn
Casual, Medicine - Med/Family and Community Medicine
BioNaomi is a fourth-year medical student at Seoul National University, expecting to graduate in February 2024. She earned her bachelor's degree Summa Cum Laude from Washington University in St. Louis in December 2018, majoring in Biology and minoring in Chinese Language & Culture. Although she has quite a long way to go before becoming a compassionate physician-scientist, Naomi has accumulated many years of research and clinical experience in the field of medicine, ranging from the molecular level to the population level. Her research interests lie in genomics, psychosomatic medicine, and global health.
-
Israt Alam
Senior Research Scientist-Basic Life, Rad/Molecular Imaging Program at Stanford
BioResearch Focus and interests: Molecular Imaging, Clinical Translation, Graft versus Host Disease, Spatial Biology, Immune-Theragnostics
Dr. Israt Alam is a Senior Scientist in the Radiology Department at Stanford University. She trained in Prof. Sanjiv Sam Gambhir's lab and transitioned to Dr. Michelle James' lab in 2021. Her research focuses on studying lymphocyte activation with the motivation of developing non-invasive imaging tools, to monitor immune dynamics in response to cancer immunotherapy and in immunopathology. Her work has supported the clinical translation of several nuclear imaging agents (small molecules and a biologic) for early detection of cancer and prediction of treatment response, that are being evaluated in oncology trials around the world. She is currently leading the IND-enabling studies for a first in class PET tracer for T cell activation and has also supported several biomarker detection platforms for early disease detection. She was elected as Co-Chair of the "Imaging in cell and immune therapies" (ICIT) interest group for the World Molecular Imaging Society (WMIS).
Key funding: (grant conceptualization/scientific lead): NIH/NCI R01, Pfizer Inc., SNMMI Education and Research Foundation
Appointments:
-Senior Research Scientist, James Lab, Department of Radiology, Stanford
-Life Sciences Research Associate, Gambhir Lab, Department of Radiology, Stanford
-Post-Doctoral Scholar, Gambhir Lab, Department of Radiology, Stanford
-Churchill Travel Fellow in the Plateforme d'imagerie dynamique lab of Prof. Spencer Shorte, Pasteur Institute, Paris
-Science Education Consultant: United Nations Educational, Science and Cultural Organization (UNESCO), Paris
-Science Education Intern: United Nations Educational, Science and Cultural Organization (UNESCO), Paris -
Arash Alavi
Software Engineering Director, Genetics
Current Role at StanfordSoftware Engineering Director
-
Alawab Aldulimy
Clinical Rsch Coord Assoc, CV Med - Clinical Trials
Current Role at StanfordClinical Researcher
Clinical Research Coordinator -
William Alegria
Lecturer, Medicine - Med/Infectious Diseases
BioDr. Alegria is a board-certified Infectious Diseases Pharmacotherapy specialist and antimicrobial stewardship consultant with the Stanford Antimicrobial Safety and Sustainability Program. He primarily practices in the inpatient setting and is dedicated to developing targeted stewardship interventions in immunocompromised patient populations. His clinical interests include management of infections in immunocompromised hosts, antifungal pharmacotherapy, and difficult-to-treat infections.
Publications (selected)
Navigating recurrent Clostridioides difficile infection without Bezlotoxumab: potential challenges ahead. Arya R, Zimmet AN, Holubar M, Alegria W. Antimicrob Steward Healthc Epidemiol. 2025
How to leverage medication use evaluations for antimicrobial stewardship goals: a primer for physicians. Prasad R, Arya R, Meng L, Holubar M, Alegria W, Zimmet AN.
Antimicrob Steward Healthc Epidemiol. 2025
Beyond the basics: rethinking antimicrobial stewardship by targeting cytomegalovirus immune globulin for immunocompromised patients. Prasad R, Lu B, Veloria D, Mui E, Nelson J, Dhillon G, Deresinski S, Holubar M, Alegria W. Antimicrob Steward Healthc Epidemiol. 2025
No "One-Size-Fits All": chronic "Carryover" diagnoses dilute antibiotic prescribing rates for sinusitis among adults in primary and urgent care settings. Smith M, Hawkins M, Laikijrung C, Mui E, Alegria W, Leung T, Zimmet A, Ha D, Holubar M. Infect Control Hosp Epidemiol. 2024
Combination Antifungal Therapy for Invasive Mucormycosis in Immunocompromised Hosts: A Single-Center Experience. Lu B, Ha D, Shen S, Ferguson Toll J, Kim A, Kim S, Mui E, Deresinski S, Holubar M, Alegria W. Open Forum Infect Dis. 2024
"Electronic Phenotyping" Antimicrobials to Facilitate Outpatient Stewardship for Asymptomatic Bacteriuria and Urinary Tract Infection in Renal Transplant. Zimmet AN, Ha D, Mui E, Smith M, Hawkins M, Alegria W, Holubar M. Open Forum Infect Dis. 2024
Risk factors and outcomes associated with persistent vancomycin resistant Enterococcal Bacteremia. Fox E, Ha D, Bounthavong M, Meng L, Mui E, Holubar M, Deresinski S, Alegria W. BMC Infect Dis. 2022
Shorter durations of antibiotic therapy in organ transplant. Alegria W, Medvedeva N, Holubar M. Curr Opin Organ Transplant. 2022
Characterisation of infections in patients with acute myeloid leukaemia receiving venetoclax and a hypomethylating agent. On S, Rath CG, Lan M, Wu B, Lau KM, Cheung E, Alegria W, Young R, Tan M, Kim C, Phun J, Patel N, Mannis G, Logan AC, Kennedy V, Goodman A, Taplitz RA, Young PA, Wen R, Saunders IM. Br J Haematol. 2022
Early Antibiotic Discontinuation or De-escalation in High-Risk Patients With AML With Febrile Neutropenia and Prolonged Neutropenia. Alegria W, Marini BL, Gregg KS, Bixby DL, Perissinotti A, Nagel J. J Natl Compr Canc Netw. 2022
Effect of rapid methicillin-resistant Staphylococcus aureus nasal polymerase chain reaction screening on vancomycin use in the intensive care unit. Diep C, Meng L, Pourali S, Hitchcock MM, Alegria W, Swayngim R, Ran R, Banaei N, Deresinski S, Holubar M. Am J Health Syst Pharm. 2021 Dec
The Current State of Antifungal Stewardship in Immunocompromised Populations. Alegria W, Patel PK. J Fungi (Basel). 2021
Bacteremia due to Methicillin-Resistant Staphylococcus aureus: An Update on New Therapeutic Approaches. Holubar M, Meng L, Alegria W, Deresinski S. Infect Dis Clin North Am. 2020
Impact of Rapid Antimicrobial Susceptibility Testing in Gram-Negative Rod Bacteremia: a Quasi-experimental Study. Hogan CA, Ebunji B, Watz N, Kapphahn K, Rigdon J, Mui E, Meng L, Alegria W, Holubar M, Deresinski S, Banaei N. J Clin Microbiol. 2020
Antimicrobial Stewardship in Cancer Patients: The Time is Now. Aitken SL, Nagel JL, Abbo L, Alegria W, Barreto JN, Dadwal S, Freifeld AG, Jain R, Pergam SA, Tverdek FP, Seo SK; Antimicrobial Stewardship in Cancer Consortium ASCC. J Natl Compr Canc Netw. 2019 -
Dr. Lydia Aletraris
Social Science Research Scholar, Health Policy
BioDr. Lydia Aletraris brings both a national and global perspective to her research, specializing in substance use and human trafficking. With extensive experience managing projects funded by agencies such as the National Institutes of Health, the Substance Abuse and Mental Health Services Administration, the U.S. Department of Justice, and the U.S. Department of State, she has served as Principal Investigator or Co-Principal Investigator on national research examining the implementation of evidence-based practices in substance use treatment and the effects of U.S. cannabis policy, as well as on international research focused on human trafficking.
Dr. Aletraris previously coordinated the Prevalence Reduction Innovation Forum (PRIF), a global initiative that developed key trafficking indicators and brought together scholars from around the world to test methodologies for measuring human trafficking prevalence, with studies conducted in Brazil, Costa Rica, Morocco, Pakistan, Tanzania, and Tunisia.
With a commitment to health and human rights, her research addresses urgent public health challenges through ethical, evidence-based practices and policies that support resilience and recovery across diverse, at-risk populations. Dr. Aletraris holds a PhD in Sociology from the University of Georgia. -
Mostafa H. Algabri
Visiting Instructor,
BioMostafa Hikmat Saeed Algabri, M.B.Ch.B., is a physician and clinical researcher currently serving as a visiting instructor in the Department of Neurosurgery at Stanford University School of Medicine. His research focuses on stereotactic radiosurgery (SRS), neurovascular disease, and advanced neuroimaging, with particular interest in evaluating the outcomes, indications, and adverse effects of radiosurgical interventions in neurosurgical disorders such as arteriovenous malformations, vestibular schwannomas, meningiomas, and paragangliomas.
Dr. Algabri graduated from the College of Medicine at the University of Baghdad and is ECFMG-certified. He successfully completed the United States Medical Licensing Examination (USMLE) steps 1 and 2 (CK). He has authored numerous peer-reviewed publications in neurosurgery, neurology, and neuroradiology journals and actively collaborates on international research projects involving cerebrovascular disease, spine surgery, and neurosurgical outcomes research.
In addition to his work at Stanford, Dr. Algabri serves as a peer reviewer for several scientific journals, including World Neurosurgery, World Neurosurgery: X, Journal of Clinical Neuroscience, Interdisciplinary Neurosurgery, and Cureus.
Dr. Algabri is the founder of the NeuroResearch Circle academic platform and the developer of the Stroke Localizer educational system designed to teach stroke localization and neuroanatomy through interactive learning. His research has been presented at international scientific meetings, including the Congress of Neurological Surgeons (CNS), the Academic International Medical Summit (AIMS), and the International Student Congress of (Bio)Medical Sciences (ISCOMS). In 2025, he received the Ideal Physician Award from the Iraqi Medical Association in recognition of his dedication to patient care, professionalism, and contributions to academic medicine.
